CLINICAL_TRIALS
research
· 2024-08-06
Clinical Trial Update: Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout
Summary
A clinical trial update examining the role of the NLRP3 inflammasome in intercritical gout, currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Attune Health Research, Inc. | Conditions: Gout | Status: ACTIVE_NOT_RECRUITING